CN108635516A - 一种调节血糖、血脂颗粒冲剂的配方及其制备方法 - Google Patents

一种调节血糖、血脂颗粒冲剂的配方及其制备方法 Download PDF

Info

Publication number
CN108635516A
CN108635516A CN201810464359.2A CN201810464359A CN108635516A CN 108635516 A CN108635516 A CN 108635516A CN 201810464359 A CN201810464359 A CN 201810464359A CN 108635516 A CN108635516 A CN 108635516A
Authority
CN
China
Prior art keywords
formula
preparation
grams
milligrams
blood glucose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201810464359.2A
Other languages
English (en)
Inventor
刘建孚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shenzhen Xin Yongkang Biotechnology Development Co Ltd
Original Assignee
Shenzhen Xin Yongkang Biotechnology Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shenzhen Xin Yongkang Biotechnology Development Co Ltd filed Critical Shenzhen Xin Yongkang Biotechnology Development Co Ltd
Priority to CN201810464359.2A priority Critical patent/CN108635516A/zh
Publication of CN108635516A publication Critical patent/CN108635516A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51—Thiamines, e.g. vitamin B1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/733—Fructosans, e.g. inulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/42—Cucurbitaceae (Cucumber family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/482—Cassia, e.g. golden shower tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/488—Pueraria (kudzu)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
    • A61K36/605—Morus (mulberry)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Polymers & Plastics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Diabetes (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

本发明公开了一种调节血糖、血脂颗粒冲剂的配方及其制备方法，包括苦荞麦30—40克、苦瓜20—30克、葛根10—20克、桑叶10—20克、决明子10—20克、玉米须5—10克、菊粉5—10克、维生素A：400—1700微克、维生素B1：0.9—2.2毫克、维生素B：20.9—2.2毫克、维生素C：100—225毫克、叶酸60—600微克、泛酸2.2—8毫克、钙250—1000毫克、铁9.5—22毫克、锌6—18毫克、阿斯巴甜；其中阿斯巴甜含苯丙氨酸。锌可以为乳酸锌。本发明通过设计出一种调节血糖、血脂颗粒冲剂的配方及其制备方法实现糖尿病患者可食用此冲剂进行对血糖和血脂的稳定性控制。

Description

一种调节血糖、血脂颗粒冲剂的配方及其制备方法
技术领域
本发明涉及一种保健食品，尤其是一种调节血糖、血脂颗粒冲剂的配方及其制备方法。
背景技术
目前糖尿病患者逐年增加，糖尿病分为1型和2型，前者患病少，病程短，对胰岛素治疗效果好；而后者患病率高，病程长，有严重的合并症，对胰岛素等治疗效果差，要想控制好病情，除了积极治疗，还要避免常犯的一些错误。专家提醒，血糖和血脂控制不佳的患者不妨从自己身上找找原因。美国俄勒冈卫生与科技大学糖尿病健康中心主任安德鲁·阿曼博士表示，糖尿病患者看医生的时间是有限的，在99.9％的时间里，糖友是自己的“医生”。如果不了解糖尿病，不了解自己的身体状况，饮食、锻炼、吃药的效果就会打折扣。不控制饮食。饮食治疗是糖尿病治疗的基础，其目的是减轻胰岛β细胞的负担，以帮助其恢复功能。有的人认为吃降糖药了就不用控制饮食，大吃大喝，甚至大量饮酒。还有的人错误地认为控制饮食，生活就没有质量了，其结果必然是血糖和血脂长期居高不下。
因此，设计出一种调节血糖、血脂颗粒冲剂的配方及其制备方法是行业期待解决的问题。
发明内容
为了解决上述现有技术中存在的问题，本发明提出一种调节血糖、血脂颗粒冲剂的配方及其制备方法，包括苦荞麦30—40克、苦瓜20—30克、葛根10—20克、桑叶10—20克、决明子10—20克、玉米须5—10克、菊粉5—10克、维生素A：400—1700微克、维生素B1：0.9—2.2毫克、维生素B2：0.9—2.2毫克、维生素C：100—225毫克、叶酸60—600微克、泛酸2.2—8毫克、钙250—1000毫克、铁9.5—22毫克、锌6—18毫克、阿斯巴甜；其中阿斯巴甜含苯丙氨酸。所述锌可以为乳酸锌。
进一步，所述维生素A为醋酸维生素A。
进一步，所述维生素B1为盐酸硫安素。
进一步，所述维生素B2为核黄素。
进一步，所述维生素C为L—抗坏血酸。
进一步，所述叶酸为蝶酰谷氨酸。
进一步，所述泛酸为D—泛酸钠。
进一步，所述钙为乳酸钙。
进一步，所述铁为乳酸亚铁。
进一步，所述锌为乳酸锌。
与现有的技术相比，本发明具有以下优点：
通过设计出一种调节血糖、血脂颗粒冲剂的配方及其制备方法实现糖尿病患者可食用此冲剂进行对血糖和血脂的稳定性控制。
具体实施方式
为了更充分理解本发明的技术内容，下面对本发明进一步进行说明，但不局限于此。
为了解决上述现有技术中存在的问题，本发明提出一种调节血糖、血脂颗粒冲剂的配方及其制备方法，包括苦荞麦35克、苦瓜25克、葛根15克、桑叶15克、决明子15克、玉米须7.5克、菊粉7.5克、维生素A：1000微克、维生素B1：2.0毫克、维生素B2:1.1毫克、维生素C：125毫克、叶酸500微克、泛酸5毫克、钙600毫克、铁10.5毫克、锌12毫克、阿斯巴甜；其中阿斯巴甜含苯丙氨酸。锌可以为乳酸锌。
本发明优选一实施例中，维生素A为醋酸维生素A。
本发明优选一实施例中，维生素B1为盐酸硫安素。
本发明优选一实施例中，维生素B2为核黄素。
本发明优选一实施例中，维生素C为L—抗坏血酸。
本发明优选一实施例中，叶酸为蝶酰谷氨酸。
本发明优选一实施例中，泛酸为D—泛酸钠。
本发明优选一实施例中，钙为乳酸钙。
本发明优选一实施例中，铁为乳酸亚铁。
本发明优选一实施例中，锌为乳酸锌。
综上，通过设计出一种调节血糖、血脂颗粒冲剂的配方及其制备方法实现糖尿病患者可食用此冲剂进行对血糖和血脂的稳定性控制。
以上的具体实施例仅用以举例说明本发明的构思，本领域的普通技术人员在本发明的构思下可以做出多种变形和变化。这些变形和变化均包括在本发明的保护范围之内。

Claims (10)

1.一种调节血糖、血脂颗粒冲剂的配方及其制备方法，其特征在于，包括苦荞麦30—40克、苦瓜20—30克、葛根10—20克、桑叶10—20克、决明子10—20克、玉米须5—10克、菊粉5—10克、维生素A:400—1700微克、维生素B1:0.9—2.2毫克、维生素B2:0.9—2.2毫克、维生素C:100—225毫克、叶酸60—600微克、泛酸2.2—8毫克、钙250—1000毫克、铁9.5—22毫克、锌6—18毫克、阿斯巴甜；其中阿斯巴甜含苯丙氨酸。
2.如权利要求1所述调节血糖、血脂颗粒冲剂的配方及其制备方法，其特征在于，所述维生素A为醋酸维生素A。
3.如权利要求1所述调节血糖、血脂颗粒冲剂的配方及其制备方法，其特征在于，所述维生素B1为盐酸硫安素。
4.如权利要求1所述调节血糖、血脂颗粒冲剂的配方及其制备方法，其特征在于，所述维生素B2为核黄素。
5.如权利要求1所述调节血糖、血脂颗粒冲剂的配方及其制备方法，其特征在于，所述维生素C为L—抗坏血酸。
6.如权利要求1所述调节血糖、血脂颗粒冲剂的配方及其制备方法，其特征在于，所述叶酸为蝶酰谷氨酸。
7.如权利要求1所述调节血糖、血脂颗粒冲剂的配方及其制备方法，其特征在于，所述泛酸为D—泛酸钠。
8.如权利要求1所述调节血糖、血脂颗粒冲剂的配方及其制备方法，其特征在于，所述钙为乳酸钙。
9.如权利要求1所述调节血糖、血脂颗粒冲剂的配方及其制备方法，其特征在于，所述铁为乳酸亚铁。
10.如权利要求1所述调节血糖、血脂颗粒冲剂的配方及其制备方法，其特征在于，所述锌为乳酸锌。
CN201810464359.2A 2018-05-15 2018-05-15 一种调节血糖、血脂颗粒冲剂的配方及其制备方法 Pending CN108635516A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810464359.2A CN108635516A (zh) 2018-05-15 2018-05-15 一种调节血糖、血脂颗粒冲剂的配方及其制备方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810464359.2A CN108635516A (zh) 2018-05-15 2018-05-15 一种调节血糖、血脂颗粒冲剂的配方及其制备方法

Publications (1)

Publication Number Publication Date
CN108635516A true CN108635516A (zh) 2018-10-12

Family

ID=63756029

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810464359.2A Pending CN108635516A (zh) 2018-05-15 2018-05-15 一种调节血糖、血脂颗粒冲剂的配方及其制备方法

Country Status (1)

Country Link
CN (1) CN108635516A (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115500439A (zh) * 2021-06-23 2022-12-23 陕西罗麻丹医药有限公司 一种调节血糖血脂的固体饮料及其制备方法

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101474304A (zh) * 2008-12-15 2009-07-08 北京利千秋科技发展有限公司 用于降低血糖与血脂的药物组合物
CN101574368A (zh) * 2009-03-17 2009-11-11 北京利千秋科技发展有限公司 用于降低血糖和血脂的药物组合物
CN101584736A (zh) * 2009-04-01 2009-11-25 北京利千秋科技发展有限公司 用于降低血糖与血脂和治疗糖尿病的药物组合物
CN101596276A (zh) * 2009-03-19 2009-12-09 北京利千秋科技发展有限公司 用于降低血糖与血脂和治疗糖尿病的药物组合物
CN101596284A (zh) * 2009-03-19 2009-12-09 北京利千秋科技发展有限公司 用于降低血糖和血脂的药物组合物
CN102488281A (zh) * 2011-12-14 2012-06-13 大连蓝德奥科技有限公司 一种具有降血糖作用的新型纯植物复合浓缩饮液及其制法
CN103431391A (zh) * 2013-08-28 2013-12-11 张秀平 综合营养粉
CN103933420A (zh) * 2014-03-22 2014-07-23 南通蛇类治疗研究所 天然绿色元素中药降控血糖多瓜粉
CN104856003A (zh) * 2015-04-23 2015-08-26 劲膳美生物科技股份有限公司 糖尿病非全营养配方食品
CN104855979A (zh) * 2015-04-22 2015-08-26 劲膳美生物科技股份有限公司 降血脂非全营养配方食品
CN105394182A (zh) * 2015-10-27 2016-03-16 江西美庐乳业集团有限公司 一种具有降血糖功效及促进心脑血管健康的营养包

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101474304A (zh) * 2008-12-15 2009-07-08 北京利千秋科技发展有限公司 用于降低血糖与血脂的药物组合物
CN101574368A (zh) * 2009-03-17 2009-11-11 北京利千秋科技发展有限公司 用于降低血糖和血脂的药物组合物
CN101596276A (zh) * 2009-03-19 2009-12-09 北京利千秋科技发展有限公司 用于降低血糖与血脂和治疗糖尿病的药物组合物
CN101596284A (zh) * 2009-03-19 2009-12-09 北京利千秋科技发展有限公司 用于降低血糖和血脂的药物组合物
CN101584736A (zh) * 2009-04-01 2009-11-25 北京利千秋科技发展有限公司 用于降低血糖与血脂和治疗糖尿病的药物组合物
CN102488281A (zh) * 2011-12-14 2012-06-13 大连蓝德奥科技有限公司 一种具有降血糖作用的新型纯植物复合浓缩饮液及其制法
CN103431391A (zh) * 2013-08-28 2013-12-11 张秀平 综合营养粉
CN103933420A (zh) * 2014-03-22 2014-07-23 南通蛇类治疗研究所 天然绿色元素中药降控血糖多瓜粉
CN104855979A (zh) * 2015-04-22 2015-08-26 劲膳美生物科技股份有限公司 降血脂非全营养配方食品
CN104856003A (zh) * 2015-04-23 2015-08-26 劲膳美生物科技股份有限公司 糖尿病非全营养配方食品
CN105394182A (zh) * 2015-10-27 2016-03-16 江西美庐乳业集团有限公司 一种具有降血糖功效及促进心脑血管健康的营养包

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
王红等: "唐一泰胶囊降糖效果观察", 《中国城乡企业卫生》 *
郑瑶琴，聂恒环，邱玉芳，邢国庆，高允生: "脂降宁片对高血脂大鼠的降脂效应", 《泰山医学院学报》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115500439A (zh) * 2021-06-23 2022-12-23 陕西罗麻丹医药有限公司 一种调节血糖血脂的固体饮料及其制备方法

Similar Documents

Publication Publication Date Title
Wilson Pathophysiology, prevention, and treatment of beriberi after gastric surgery
CN109123619A (zh) 一种供糖尿人群食用营养粉的配方及制备方法
Obeagu et al. Megaloblastic anaemia-a review
TW201828955A (zh) 提高耐力表現之抗疲勞組合物
CN108635516A (zh) 一种调节血糖、血脂颗粒冲剂的配方及其制备方法
US11219663B2 (en) Composition containing cyclic dipeptide and sweetening agent
CN101269210A (zh) 适用治疗难治性癫痫的生酮混合制剂
CN107223981B (zh) 含大豆多肽阿格拉欣的组合物及其制备方法
CN104770644A (zh) 一种基于药食同源的糖尿病保健品
Kurtoglu et al. Thiamine withdrawal can lead to diabetic ketoacidosis in thiamine responsive megaloblastic anemia: report of two siblings
CN108522603A (zh) 一种辅助调节血糖、血脂饼干的配方及其制备方法
CN108077730A (zh) 一种糖尿病人专用面粉及其制作方法
CN108576230A (zh) 一种辅助调节血糖、血脂奶粉的配方及制备方法
CN108719785A (zh) 一种辅助调节血糖面条的配方及制备方法
JP2004201675A (ja) 糖尿病予防効果を有する亜鉛高含有食品
Sunitha et al. Wernicke-Korsakoff Syndrome: An Overview
CN111513312A (zh) 含藜麦的全营养特殊医学用途配方食品及其制备方法
CN109123626A (zh) 一种糖尿人群食用粥类的配方及制备方法
CN105685737B (zh) 低血糖指数的运动饮料及其制备和使用方法
US20200306231A1 (en) Oral hypoglycemic agents as food additives and supplements
Borreggine et al. Psychiatric manifestations of hyperammonemic encephalopathy following roux-en-y gastric bypass
JP7430442B2 (ja) グレリン受容体の活性化剤
CN107094893A (zh) 一种富铬奶粉
US20230112660A1 (en) Sweetener and manufacturing process therefor
CN108402251A (zh) 一种调节三高人群血糖、血脂饮用茶的配方及制备方法

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20181012